Vertex Pharmaceuticals Inc / Ma

NEW YORK LIFE INVESTMENT MANAGEMENT LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

36,818

Value ($000)

16,692

Weight

0.1%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	16,692	0.1%	36,818	12/31/2025
2025 Q3	11/6/2025	14,660	0.1%	37,432	9/30/2025
2025 Q2	8/1/2025	17,318	0.2%	38,900	6/30/2025
2025 Q1	5/8/2025	18,717	0.2%	38,606	3/31/2025
2024 Q4	2/5/2025	15,729	0.2%	39,060	12/31/2024
2024 Q3	11/7/2024	17,988	0.2%	38,677	9/30/2024
2024 Q2	8/5/2024	18,499	0.2%	39,466	6/30/2024
2024 Q1	5/6/2024	16,330	0.2%	39,065	3/31/2024
2023 Q4	2/6/2024	16,442	0.2%	40,409	12/31/2023
2023 Q3	11/8/2023	16,605	0.2%	47,751	9/30/2023
2023 Q2	8/7/2023	17,312	0.2%	49,195	6/30/2023
2023 Q1	5/8/2023	15,574	0.2%	49,430	3/31/2023
2022 Q4	2/10/2023	15,163	0.2%	52,506	12/31/2022
2022 Q3	11/10/2022	15,273	0.2%	52,748	9/30/2022
2022 Q2	8/12/2022	15,089	0.2%	53,540	6/30/2022